Literature DB >> 6584678

Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.

R W Chesney, A J Hamstra, M Phelps, H F DeLuca.   

Abstract

Serum vitamin D metabolites were measured in relation to factors responsible for the synthesis of 1,25(OH)2D in children with renal disease and other disorders of vitamin D metabolism. Severe renal failure (CCr less than 15 ml/min/1.73 m2) was associated with a reduction in 1,25(OH)2D to 25% of mean normal levels, a very high PTH/1,25(OH)2D ratio of 75 (normal = 0.74), and a 60% reduction of serum 24,25(OH)2D. At CCr values between 15 and 50 ml/min 1.73 m2, 1,25(OH)2D was 50% of normal, despite a PTH/1,25(OH)2D ratio of 7 and a normal 24,25(OH)2D value. Above clearance values of 75 ml/min/1.73 m2, 1,25(OH)2D and the ratio were normal. Oral 1,25(OH)2D therapy in severe chronic renal insufficiency caused a fall in this ratio from 75 to 8. High PTH/1,25(OH)2D ratios were found in hypophosphatemic rickets and vitamin D-deficiency rickets, indicating reduced synthesis of 1,25(OH)2D relative to PTH. Low ratios were found in hypoparathyroidism and sarcoidosis, possibly indicating independence of PTH stimulation in 1,25(OH)2D production. The ratios of calcium/1,25(OH)2D and phosphate/1,25(OH)2D also provided useful information in each of these conditions, indicating that the use of such series of ratios in selected patients may promote a better understanding of pathogenic mechanisms and of the response to therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6584678

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  2 in total

1.  Recent developments in vitamin D metabolism and its clinical application for renal disease.

Authors:  R W Chesney
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 2.  Nutritional management of children with chronic renal failure. Summary of the task force on nutritional management of children with chronic renal failure.

Authors:  S Hellerstein; M A Holliday; W E Grupe; R N Fine; R S Fennell; R W Chesney; J C Chan
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.